Table 2.
Joinpoint analysis of age-standardizedb mortality rate from cancer and cardiovascular diseases (CVD) by sex
| Absolute deaths (Rate per 100,000) | Total study periodc | Period 1 | Period 2 | Period 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1983 | 2013 | Average APC (%) | 95%CI | Years | APC (%) | Years | APC (%) | Years | APC (%) | |
| Cancer | ||||||||||
| Male | 80,553 (464.9) | 87,511 (350.9) | -1.0a | −1.1, −0.8 | 1983–1991 | 0.0 | 1991–1997 | −1.8a | 1997–2013 | −1.2a |
| Female | 71,265 (277.3) | 78,331 (242.7) | −0.5a | −0.6, −0.4 | 1983–1989 | 0.7a | 1989–1997 | −1.0a | 1997–2013 | −0.7a |
| CVD | ||||||||||
| Male | 158,944 (1035.3) | 79,935 (334.3) | −3.9a | −4.0, −3.7 | 1983–2001 | −2.8a | 2001–2013 | −5.4a | ||
| Female | 164,349 (665.8) | 79,860 (227.9) | −3.7a | −3.8, −3.5 | 1983–2003 | −2.7a | 2003–2013 | −5.6a | ||
aSignificantly different from zero (p < 0.05)
b Standardized to the 2013 European standard population by 5-year age groups
c Years 1983 to 2013
APC, annual percentage change